NOVEN TO PRESENT AT DEUTSCHE BANK HEALTH CARE CONFERENCE

Back

Miami, FL, April 26, 2005 -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven’s business and prospects on Monday, May 2, 2005 at 1:30 p.m. Eastern Time at the Deutsche Bank 30th Annual Health Care Conference in Baltimore. A live webcast of the presentation will be accessible to the public at www.noven.com and a rebroadcast will be available thereafter at the same site.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Back

Copyright ©  2005 Noven Pharmaceuticals, Inc. All rights reserved.